While pharmaceutical innovation has improved the quality of life, there remains a wide range of challenges facing the industry. The Rutgers Mini-MBA™: BioPharma Innovation program explores new business models and the vision required to address these challenges. Learning is focused on building business skills tailored to the needs of the Biotech and Pharmaceutical industries, while challenging participants to consider new business paradigms promoting sustainable revenue growth, stakeholder cooperation, and cost management in a capstone session.
Twelve 3-hour modules. Must attend a Minimum of 10 sessions to earn a certificate.
In the spirit of transformation, we have incorporated digital technology for this program. All participants will be supplied with their own Apple® iPad™ to deliver the course content.
The Mini-MBA™: BioPharma Innovation is a certificate program for:
This program provides participants with an understanding of:
After completing the program, participants will be familiar with how key functions work together to develop a successful drug, as well as how researching, modeling, and projecting market opportunities for specific therapeutic areas create future market opportunities.
The Rutgers Mini-MBA™: BioPharma Innovation features focused learning experiences and case studies on vital subject areas in today’s rapidly changing industry environment. Twelve sessions are delivered in three-hour modules. To see a detailed description of the program, please download the program brochure.Topics may include: